Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulse rhythm

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Management of Gunshot Injury Involving Cardiac Implantable Electronic Device.

JACC. Case reports·2025

Same author

A dual-chamber leadless pacemaker in d-TGA patient after senning procedure.

HeartRhythm case reports·2025

Same author

Real-World Impact of Mavacamten on Diastolic Function in Hypertrophic Cardiomyopathy: Insights Beyond Gradient Reduction.

The American journal of cardiology·2025

Same author

The impact of SGLT-2 Inhibitors on the Risk of Atrial Fibrillation in Heart Failure.

medRxiv : the preprint server for health sciences·2025

Same author

Physiology of Pacing Symposium 2024: Letter from the Program Directors.

The Journal of innovations in cardiac rhythm management·2025

Same author

Conduction system pacing: overview, definitions, and nomenclature.

European heart journal supplements : journal of the European Society of Cardiology·2023

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Translational Rabbit Model of Chronic Cardiac Pacing

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

Modern pacemakers: hope or hype?

Mithilesh K DAS¹, Gopi Dandamudi, Hillel A Steiner

¹Krannert Institute of Cardiology, Roudebush VA Medical Center, Indiana University School of Medicine, Indianapolis, Indiana, USA. midas@iupui.edu

Pacing and Clinical Electrophysiology : PACE

|September 2, 2009

Summary

Modern pacemakers offer advanced features for physiological pacing, aiming to reduce heart failure and improve patient outcomes. While benefits like reduced mortality are still under investigation, current devices show acceptable performance and safety.

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Related Experiment Videos

Last Updated: Jun 20, 2026

Translational Rabbit Model of Chronic Cardiac Pacing

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Area of Science:

Cardiology
Biomedical Engineering
Medical Devices

Background:

Implantable pacing devices have evolved beyond arrhythmia management.
Contemporary pacemakers aim to meet patients' physiological needs with advanced functionalities.

Purpose of the Study:

To review the expanded roles and functionalities of modern pacemakers.
To discuss the concept and impact of physiological pacing.
To highlight emerging technologies in pacing therapy.

Main Methods:

Review of modern pacemaker features, including dual-chamber pacing, rate-response algorithms, and cardiac resynchronization therapy (CRT).
Discussion of automaticity features for monitoring pacemaker parameters.
Analysis of physiological pacing algorithms and their clinical implications.

Main Results:

Modern pacemakers incorporate features like rate-response, CRT, and arrhythmia prevention.
Automaticity enables monitoring of battery, impedance, sensing, and thresholds.
Physiological pacing algorithms minimize ventricular pacing, potentially reducing atrial fibrillation and heart failure hospitalizations.

Conclusions:

Modern pacemakers demonstrate acceptable performance and safety for clinical needs.
Minimizing ventricular pacing is a key goal for improving patient outcomes.
New technologies promise future advancements in pacing therapy for symptomatic and mortality benefits.